Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 7
Submit an article Journal homepage
3,266
Views
1
CrossRef citations to date
0
Altmetric
Articles

Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders

Bruce Strobera Yale University, New Haven, Connecticut, and Central Connecticut Dermatology Research, Cromwell, CT, USACorrespondence[email protected]
View further author information
,
April Armstrongb Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USAView further author information
,
Simone Rubantc AbbVie, Inc., North Chicago, IL, USAView further author information
,
Manish Patelc AbbVie, Inc., North Chicago, IL, USAView further author information
,
Tianshuang Wuc AbbVie, Inc., North Chicago, IL, USAView further author information
,
Huzefa Photowalac AbbVie, Inc., North Chicago, IL, USAView further author information
&
Jeffrey Crowleyd Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, CA, USAView further author information
 show all
Pages 2991-2996 | Received 19 Apr 2022, Accepted 09 Jun 2022, Published online: 31 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.